Navigation Links
Hadasit Bio-Holdings Ltd. to Present at the Third Annual Connecticut-Israel Technology Summit
Date:6/5/2013

JERUSALEM, June 5, 2013 /PRNewswire/ -- Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), a publicly traded portfolio of biotech companies, based on intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical research center, today announced that Mr. Ophir Shahaf , Chief Executive Officer, will be presenting at the third annual Connecticut-Israel Technology Summit on June 12th at The Oakdale Theater in Wallingford, CT. 

Mr. Shahaf will discuss the six current portfolio companies in Hadasit Bio-Holdings as part of the "Introductions of Israeli Biomed Companies" segment of the conference.  In addition to Hadasit Bio-Holdings, there are currently 20 community leaders, businesses, and institutions slated to participate, including Hartford Hospital, Gartner, Briefcam, The Hartford, United Technologies Corporation, the University of Connecticut, the Department of Economic and Community Development, and the Binational Industrial Research and Development Foundation.

"I am eager and excited to present our story to this targeted group of businesses and individuals looking to advance partnerships with Israeli companies," said Mr. Shahaf.  "Our unique business model and relationship to the Hadassah Hospitals in Israel has afforded us the opportunity to obtain world-class scientific research, turn this research into fully functioning companies and then further advance the companies through the help of our public company vehicle.  I look forward to discussing our story and potential strategic partnerships with the attendees of the conference."

The conference, which begins at 11 a.m. and ends at 6 p.m., will focus on building partnerships between Israeli companies and Connecticut. The organizers' goal is to encourage Israeli companies to locate their U.S. offices in Connecticut and to assist existing businesses in the state in partnering with Israeli technology companies. Part of the June 12th summit will be devoted to group roundtable discussions and other networking opportunities. Four companies will be recognized for successfully forming partnerships.

For more information about Hadasit Bio-Holdings please visit: www.hbl.co.il

Investor Contact:
KCSA Strategic Communications
Phil Carlson / Josh Dver
212.896.1233 / 1239
pcarlson@kcsa.com / jdver@kcsa.com


'/>"/>
SOURCE Hadasit Bio-Holdings Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Hadasit Bio-Holdings Ltd. Reports Significant External Financing for Portfolio Companies
2. KAHR Medical, a Hadasit Bio-Holdings Portfolio Company, to Raise $2.6 Million
3. Hadasit Bio-Holdings Interviewed by Wall Street Reporter
4. Hadasit Bio-Holdings Ltd. Portfolio Companies - ProtAb Ltd. and KAHR Medical Ltd. to Receive NIS 10.7 Million (Over $2.8 Million USD) in Additional Government Grants
5. Hadasit Bio-Holdings CEO Letter to Shareholders
6. Keryx Biopharmaceuticals, Inc. Announces Upcoming Poster Presentations of Zerenex™ (Ferric Citrate) at the Upcoming American Society of Nephrology Kidney Week 2011 Annual Meeting
7. ChemoCentryx Presents Positive Results for Novel CCR2 Inhibitor in Preclinical Models of Diabetic Nephropathy at the 44th Annual Meeting of the American Society of Nephrology
8. Organovo to Present at Lazard Capital Markets 8th Annual Healthcare Conference
9. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
10. Pharmasset to Present at the Lazard Capital Markets Healthcare Conference
11. Masimo to Present at 23rd Annual Piper Jaffray Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... -- According to a new market research ... (CD34, PBMC, BLT)), Application (Neuroscience, Hematopoiesis, Oncology, Immunology & ... CRO) - Global Forecast to 2021", published by MarketsandMarkets, ... for the forecast period of 2016 to 2021. This ... 2021 from USD 73.3 Million in 2016, growing at ...
(Date:1/24/2017)... - BioAmber Inc. (NYSE: BIOA ) today announced ... Rodman & Renshaw, a unit of H.C. Wainwright ... representative of several underwriters, under which the underwriters have ... minimum of 2,105,264 shares of common stock of the ... 1,052,632 shares of common stock of the Company with ...
(Date:1/23/2017)... 23, 2017   Enteris BioPharma, Inc. , announced ... Sanofi to leverage Enteris, proprietary and patented ... develop an oral formulation of one of Sanofi,s preclinical ... Chief Executive Officer and Executive Chairman of Enteris BioPharma, ... the tremendous value our Peptelligence platform program offers in ...
(Date:1/23/2017)... , ... January 23, 2017 , ... ... been appointed Vice President, Preclinical Safety and Senior Director, Safety Pharmacology. Dr. ... in India. , Dr. Thomas’ career as an academic and industry preclinical ...
Breaking Biology Technology:
(Date:12/20/2016)... 2016 The rising popularity of mobility ... is stoking significant interest in keyless access systems. ... low energy (BLE), biometrics and near-field communication (NFC) ... of wireless technologies in the automotive industry. This ... access systems opens the market to specialist companies ...
(Date:12/19/2016)... y TORONTO , 19 de diciembre de 2016 ... Inc. que permitirá el desarrollo acelerado de MSC-1, un anticuerpo humanizado ... tipos de tumor en 2017, con múltiples sitios previstos a lo ... ... objetivo en el factor inhibidor de leucemia (LIF), una citoquina pleiotrópica ...
(Date:12/16/2016)... 16, 2016 Research and Markets has announced ... Global Forecast to 2021" report to their offering. ... The biometric vehicle access ... a CAGR of 14.06% from 2016 to 2021. The market is ... to reach 854.8 Million by 2021. The growth of the biometric ...
Breaking Biology News(10 mins):